BioVie Inc (BIVI)
3.05
-0.06
(-1.93%)
USD |
NASDAQ |
Nov 22, 16:00
3.11
+0.06
(+1.97%)
After-Hours: 20:00
BioVie Cash from Financing (Quarterly): -0.2409M for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -0.2409M |
| June 30, 2024 | -2.50M |
| March 31, 2024 | 15.98M |
| December 31, 2023 | 4.922M |
| September 30, 2023 | -0.5942M |
| June 30, 2023 | 1.268M |
| March 31, 2023 | 9.768M |
| December 31, 2022 | 32.53M |
| September 30, 2022 | 11.81M |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 14.61M |
| September 30, 2021 | 18.51M |
| June 30, 2021 | 0.1688M |
| March 31, 2021 | 0.5166M |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 14.24M |
| June 30, 2020 | 0.3935M |
| March 31, 2020 | 0.402M |
| December 31, 2019 | 0.03M |
| September 30, 2019 | 0.50M |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2018 | 0.264M |
| September 30, 2018 | 2.532M |
| June 30, 2018 | 0.227M |
| March 31, 2018 | 0.075M |
| December 31, 2017 | 0.14M |
| September 30, 2017 | 0.22M |
| June 30, 2017 | 0.095M |
| March 31, 2017 | 0.2995M |
| December 31, 2016 | 0.0975M |
| September 30, 2016 | 0.013M |
| June 30, 2016 | -0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-2.50M
Minimum
Jun 2024
32.53M
Maximum
Dec 2022
6.090M
Average
0.4593M
Median
Cash from Financing (Quarterly) Benchmarks
| Catalyst Pharmaceuticals Inc | -5.974M |
| MediciNova Inc | -- |
| NovaBay Pharmaceuticals Inc | 2.089M |
| Palatin Technologies Inc | -0.127M |
| iBio Inc | -0.162M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.580M |
| Free Cash Flow | -19.35M |
| Free Cash Flow Per Share (Quarterly) | -0.5594 |
| Free Cash Flow Yield | -121.9% |